Oncternal Therapeutics Inc. (ONCT) Tops Q4 EPS by 1c

Oncternal Therapeutics Inc. (NASDAQ: ONCT) reported Q4 EPS of ($0.20), $0.01 better than the analyst estimate of ($0.21). Revenue for the quarter came in at $171 thousand versus the consensus estimate of $306.2 thousand.

For earnings history and earnings-related data on Oncternal Therapeutics Inc. (ONCT) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c
• Newton Golf Company (NWTG) Reports Q2 Loss of $0.49